Source: Blood Cells Molecules and Diseases. Unidades: FMRP, FM, ICB
Subjects: PROTEÍNAS QUINASES, ANTINEOPLÁSICOS, BAINHA DE MIELINA, MUTAÇÃO GENÉTICA, LEUCEMIA MIELOIDE AGUDA
ABNT
PARDUCCI, Natalia Sudan et al. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells. Blood Cells Molecules and Diseases, v. 104, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58756. Acesso em: 29 jan. 2026.APA
Parducci, N. S., Garnique, A. D. M. B., Lima, K., Carlos, J. A. E. G., Fonseca, N. P., Miranda, L. B. L. D., et al. (2024). Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells. Blood Cells Molecules and Diseases, 104. doi:10.1016/j.bcmd.2023.102799NLM
Parducci NS, Garnique ADMB, Lima K, Carlos JAEG, Fonseca NP, Miranda LBLD, Almeida BO de, Rego EM, Traina F, Machado Neto JA. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells [Internet]. Blood Cells Molecules and Diseases. 2024 ; 104[citado 2026 jan. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58756Vancouver
Parducci NS, Garnique ADMB, Lima K, Carlos JAEG, Fonseca NP, Miranda LBLD, Almeida BO de, Rego EM, Traina F, Machado Neto JA. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells [Internet]. Blood Cells Molecules and Diseases. 2024 ; 104[citado 2026 jan. 29 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58756

